Ureter Cancer
Showing 1 - 25 of >10,000
Stage 0a Renal Pelvis and Ureter Cancer AJCC v8, Stage 0a Renal Pelvis Cancer AJCC v8, Stage 0a Ureter Cancer AJCC v8 Trial in
Active, not recruiting
- Stage 0a Renal Pelvis and Ureter Cancer AJCC v8
- +17 more
- Gemcitabine Hydrochloride
-
Jacksonville, Florida
- +3 more
Jul 5, 2022
Urological Malignancies, Prostate Cancer, Renal Cell Cancer Trial in Seoul
Recruiting
- Urological Malignancies
- +4 more
-
Seoul, Korea, Republic ofYonsei Severance Hospital
Jan 30, 2023
Hydronephrosis, Infiltrating Bladder Urothelial Carcinoma Sarcomatoid Variant, Infiltrating Bladder Urothelial Carcinoma,
Active, not recruiting
- Hydronephrosis
- +18 more
- Durvalumab
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Oct 31, 2022
Locally Advanced Bladder Urothelial Carcinoma, Locally Advanced Renal Pelvis Urothelial Carcinoma, Locally Advanced Ureter
Not yet recruiting
- Locally Advanced Bladder Urothelial Carcinoma
- +31 more
- Diagnostic Laboratory Biomarker Analysis
- Nivolumab
-
Houston, TexasM D Anderson Cancer Center
Aug 18, 2022
Advanced Bladder Urothelial Carcinoma, Advanced Ureter Urothelial Carcinoma, Metastatic Bladder Urothelial Carcinoma Trial in
Recruiting
- Advanced Bladder Urothelial Carcinoma
- +23 more
- Atezolizumab
- +2 more
-
Riverside, California
- +8 more
Jul 16, 2022
Urothelial Carcinoma, Urothelial Carcinoma Recurrent, Urothelial Carcinoma Ureter Trial (Jelmyto (mitomycin) for pyelocalyceal
Not yet recruiting
- Urothelial Carcinoma
- +7 more
- Jelmyto (mitomycin) for pyelocalyceal solution
- (no location specified)
May 22, 2023
Locally Advanced Bladder Urothelial Carcinoma, Locally Advanced Renal Pelvis Urothelial Carcinoma, Locally Advanced Ureter
Recruiting
- Locally Advanced Bladder Urothelial Carcinoma
- +13 more
- Pembrolizumab
- Propranolol Hydrochloride
-
Atlanta, GeorgiaEmory University Hospital/Winship Cancer Institute
Jun 8, 2022
Primary and Metastatic Tumors in Renal Cell Carcinoma and
Recruiting
- Renal Cell Carcinoma
- +4 more
- Immune checkpoint inhibitor targeting PD1
-
Philadelphia, PennsylvaniaFox Chase Cancer Center - Philadelphia
Jan 27, 2023
Locally Advanced Renal Pelvis Urothelial Carcinoma, Locally Advanced Ureter Urothelial Carcinoma, Locally Advanced Urethral
Recruiting
- Locally Advanced Renal Pelvis Urothelial Carcinoma
- +20 more
- Atezolizumab
- +2 more
-
Duarte, California
- +16 more
Aug 10, 2022
Locally Advanced Bladder Urothelial Carcinoma, Locally Advanced Renal Pelvis Urothelial Carcinoma, Locally Advanced Ureter
Recruiting
- Locally Advanced Bladder Urothelial Carcinoma
- +18 more
- Enfortumab Vedotin
- Erdafitinib
-
Los Angeles, California
- +2 more
Jun 28, 2022
Urothelial Carcinoma of the Renal Pelvis and Ureter, Transitional Cell Cancer of the Renal Pelvis and Ureter Trial (ST-02)
Not yet recruiting
- Urothelial Carcinoma of the Renal Pelvis and Ureter
- Transitional Cell Cancer of the Renal Pelvis and Ureter
- (no location specified)
Nov 7, 2023
Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8, Locally Advanced Bladder Carcinoma
Recruiting
- Clinical Stage III Cutaneous Melanoma AJCC v8
- +41 more
- Ipilimumab
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Oct 11, 2022
Cancer, Urinary Obstruction, Malignancy Trial in Chicago (Ureteral Stent, Percutaneous Nephrostomy Tube Placement)
Not yet recruiting
- Cancer
- +5 more
- Ureteral Stent
- Percutaneous Nephrostomy Tube Placement
-
Chicago, IllinoisThe University of Chicago
Nov 28, 2022
A Genotype-Phenotype Urothelial Cancer Registry
Recruiting
- Urothelial Cancer
- +3 more
- saliva sample and questionaire
- saliva sample, questionaire
-
Basking Ridge, New Jersey
- +3 more
Jun 2, 2022
Urothelial Cancer of Renal Pelvis, Urothelial Carcinoma of the Renal Pelvis and Ureter, Urothelial Carcinoma Ureter Trial
Available
- Urothelial Cancer of Renal Pelvis
- +5 more
- Mitomycin for pyelocalyceal solution
- (no location specified)
Aug 5, 2022
Advanced Clear Cell Renal Cell Carcinoma, Infiltrating Bladder Urothelial Carcinoma, Plasmacytoid Variant, Infiltrating Bladder
Active, not recruiting
- Advanced Clear Cell Renal Cell Carcinoma
- +35 more
- Cabozantinib S-malate
- +2 more
-
Duarte, California
- +7 more
Jan 3, 2023
Combined Postoperative Radiotherapy With Kidney Sparing Surgery
Recruiting
- Locally Advanced
- Urothelial Carcinoma Ureter
- Radical surgery
- Kidney sparing surgery+Postoperative radiotheray
-
Beijing, China
- +1 more
Nov 2, 2023
Urothelial Carcinoma, Kidney Cancer, Ureter Cancer Trial in Toronto (drug, other, dietary supplement)
Completed
- Urothelial Carcinoma
- +3 more
- Denosumab
- +6 more
-
Toronto, Ontario, CanadaPrincess Margaret Cancer Centre
Nov 22, 2021
Urothelial Carcinoma Ureter, Urothelial Cancer of Renal Pelvis Trial (Mitomycin C)
Not yet recruiting
- Urothelial Carcinoma Ureter
- Urothelial Cancer of Renal Pelvis
- Mitomycin C
- (no location specified)
Jul 31, 2023
Transitional Cell Cancer of Renal Pelvis and Ureter Trial in New York, Myrtle Beach, Paris (padeliporfin VTP)
Recruiting
- Transitional Cell Cancer of Renal Pelvis and Ureter
- padeliporfin VTP
-
Albany, New York
- +6 more
Jan 3, 2023
Renal Pelvis and Ureter Urothelial Carcinoma Trial in Los Angeles (procedure, drug, biological)
Not yet recruiting
- Renal Pelvis and Ureter Urothelial Carcinoma
- Biopsy
- +5 more
-
Los Angeles, CaliforniaUCLA / Jonsson Comprehensive Cancer Center
Mar 15, 2023
Blood and Tissue Samples From Locally Recurrent or Metastatic
Recruiting
- Localized Renal Pelvis and Ureter Urothelial Carcinoma
- +10 more
- Cytology Specimen Collection Procedure
- Laboratory Biomarker Analysis
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Dec 21, 2021
Advanced Bladder Urothelial Carcinoma, Advanced Renal Pelvis Urothelial Carcinoma, Advanced Ureter Urothelial Carcinoma Trial in
Recruiting
- Advanced Bladder Urothelial Carcinoma
- +17 more
- Avelumab
- +3 more
-
Auburn, California
- +111 more
Aug 17, 2022
Distal Urethral Cancer, Proximal Urethral Cancer, Recurrent Bladder Cancer Trial in United States (afatinib dimaleate,
Recruiting
- Distal Urethral Cancer
- +8 more
- afatinib dimaleate
- laboratory biomarker analysis
-
Atlanta, Georgia
- +5 more
Sep 24, 2021
Urothelial Cancer, Metastatic Urothelial Carcinoma, Metastatic Urothelial Carcinoma of the Renal Pelvis and Ureter Trial in
Recruiting
- Urothelial Cancer
- +3 more
- Sacituzumab Govitecan (SG)
- Enfortumab vedotin-ejfv (EV)
-
Boston, MassachusettsDana Farber Cancer Institute
Sep 28, 2022